Tumour model

Reh

Acute lymphoblastoid leukemia
XenograftIn vitro

Standard of Care sensibility: Rituximab = no (30mg/kg) / Dexamethasone = no (1mg/kg).

Model characteristics

Organism
Human
Tissue of origin
T cells
Pathology
Acute lymphoblastoid leukemia
Model type
In vitro, Xenograft
Availability
Off the shelf (time of expansion)

Request this model

Tell us about your compound and your endpoints. Our team confirms feasibility, timelines and study design before any commitment.

Related models

Other models sharing the same tissue of origin.

Model
Organism
Tissue of origin
Pathology
Type
Human
T cells
Cutaneous T lymphoma
XenograftIn vitro
Human
T cells
Cutaneous T lymphoma
XenograftIn vitro

EL4

Mouse
T cells
Lymphoblastic lymphoma
SyngeneicIn vitro
Human
T cells
Leukemia
XenograftIn vitro
Human
T cells
Acute T cell leukemia
XenograftIn vitro
Human
T cells
Acute lymphoblastoid leukemia
XenograftIn vitro